Oncology Institute, Inc. (TOI)
↓ Download CSV- Sector Services
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Oncology Institute, Inc. reported revenue of $502.73M, up 27.8% from the prior year. The company ran a net loss, with a net margin of -12.1%. It held $164.66M in total assets against $180.38M in total liabilities.
Key ratios (FY2025)
-7.2%
Operating margin
-12.1%
Net margin
+27.8%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $502.73M | $393.41M | $324.24M | $252.48M | $203.00M | $187.51M | — |
| Operating Income | -$36.08M | -$60.12M | -$77.02M | -$81.95M | -$45.86M | -$8.20M | — |
| Net Income | -$60.61M | -$64.66M | -$83.07M | $152.0K | -$10.93M | -$14.32M | — |
| EPS (Diluted) | $-0.54 | $-0.71 | $-0.92 | $-0.21 | $-0.16 | $-0.24 | — |
| Total Assets | $164.66M | $172.72M | $209.24M | $261.67M | $203.44M | $65.69M | $50.0K |
| Total Liabilities | $180.38M | $169.13M | $152.22M | $138.49M | $99.28M | $37.59M | $27.3K |
| Shareholders' Equity | -$15.72M | $3.59M | $57.02M | $123.17M | $104.16M | $28.10M | $42.22M |
| Cash & Equivalents | — | — | — | — | — | $900.0K | — |
| Operating Cash Flow | -$24.59M | -$26.54M | -$36.31M | -$61.76M | -$32.68M | $508.0K | — |
| Capital Expenditures | $3.20M | $3.79M | $4.57M | $5.53M | $2.85M | $1.19M | — |
| Shares Outstanding | 98.86M | 75.74M | 74.15M | 73.27M | 73.25M | 5.75M | 5.75M |